Author Llorens, Franc

21 to 40 of 58 Items
  • 2016 Journal Article
    ​ ​Identification of new molecular alterations in fatal familial insomnia​
    Llorens, F.; Thuene, K.; Schmitz, M.; Ansoleaga, B.; Frau-Mendez, M. A.; Cramm, M. & Tahir, W. et al.​ (2016) 
    Human Molecular Genetics25(12) pp. 2417​-2436​.​ DOI: https://doi.org/10.1093/hmg/ddw108 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease​
    Podlesniy, P.; Llorens, F.; Golanska, E.; Sikorska, B.; Liberski, P. P.; Zerr, I. & Trullas, R.​ (2016) 
    Alzheimer s & Dementia12(5) pp. 546​-555​.​ DOI: https://doi.org/10.1016/j.jalz.2015.12.011 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article | 
    ​ ​Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie​
    Schmitz, M.; Cramm, M.; Llorens, F.; Candelise, N. ; Mueller-Cramm, D.; Varges, D. A. & Schulz-Schaeffer, W. J. et al.​ (2016) 
    Scientific Reports6 art. 28711​.​ DOI: https://doi.org/10.1038/srep28711 
    Details  DOI  PMID  PMC  WoS 
  • 2017 Journal Article | 
    ​ ​YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias​
    Llorens, F.; Thüne, K.; Tahir, W.; Kanata, E.; Diaz-Lucena, D.; Xanthopoulos, K. & Kovatsi, E. et al.​ (2017) 
    Molecular Neurodegeneration12(1) art. 83​.​ DOI: https://doi.org/10.1186/s13024-017-0226-4 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs​
    Llorens, F.; Karch, A.; Golanska, E.; Schmitz, M.; Lange, P.; Sikorska, B. & Liberski, P. P. et al.​ (2017) 
    Dementia and Geriatric Cognitive Disorders43(1-2) pp. 71​-80​.​ DOI: https://doi.org/10.1159/000454802 
    Details  DOI  PMID  PMC  WoS 
  • 2017 Journal Article | 
    ​ ​Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.​
    Garcia-Esparcia, P.; López-González, I.; Grau-Rivera, O.; García-Garrido, M. F.; Konetti, A.; Llorens, F. & Zafar, S. et al.​ (2017) 
    Frontiers in neurology8 art. 89​.​ DOI: https://doi.org/10.3389/fneur.2017.00089 
    Details  DOI  PMID  PMC 
  • 2018 Journal Article
    ​ ​Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases​
    Villar-Piqué, A.; Schmitz, M.; Lachmann, I.; Karch, A.; Calero, O.; Stehmann, C. & Sarros, S. et al.​ (2018) 
    Molecular Neurobiology56(4) pp. 2811​-2821​.​ DOI: https://doi.org/10.1007/s12035-018-1251-1 
    Details  DOI 
  • 2018 Book Chapter
    ​ ​Cerebrospinal fluid in Creutzfeldt–Jakob disease​
    Zerr, I.; Zafar, S.; Schmitz, M.& Llorens, F.​ (2018)
    In: Cerebrospinal Fluid in Neurologic Disorders pp. 115​-124. ​Elsevier. DOI: https://doi.org/10.1016/B978-0-12-804279-3.00008-3 
    Details  DOI 
  • 2018 Book Chapter
    ​ ​Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion​
    Schmitz, M.; Candelise, N.; Llorens, F.& Zerr, I.​ (2018)
    In:​Sigurdsson, Einar M.; Calero, Miguel; Gasset, María​ (Eds.), Methods in Molecular Biology Amyloid Proteins pp. 257​-263. ​New York, NY: ​Springer New York. DOI: https://doi.org/10.1007/978-1-4939-7816-8_16 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases​
    Zerr, I.; Schmitz, M.; Karch, A.; Villar‐Piqué, A.; Kanata, E.; Golanska, E. & Díaz‐Lucena, D. et al.​ (2018) 
    Alzheimer's & Dementia14(6) pp. 751​-763​.​ DOI: https://doi.org/10.1016/j.jalz.2017.12.008 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie​
    Llorens, F.; Barrio, T.; Correia, Â.; Villar-Piqué, A.; Thüne, K.; Lange, P. & Badiola, J. J. et al.​ (2018) 
    Molecular Neurobiology55(11) pp. 8586​-8591​.​ DOI: https://doi.org/10.1007/s12035-018-1014-z 
    Details  DOI 
  • 2018 Journal Article
    ​ ​CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD​
    Ermann, N.; Lewczuk, P.; Schmitz, M.; Lange, P.; Knipper, T.; Goebel, S. & Kornhuber, J. et al.​ (2018) 
    Annals of Clinical and Translational Neurology5(7) pp. 883​-887​.​ DOI: https://doi.org/10.1002/acn3.584 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Variably protease‐sensitive prionopathy presenting within ALS/FTD spectrum​
    Vicente‐Pascual, M.; Rossi, M.; Gámez, J.; Lladó, A.; Valls, J.; Grau‐Rivera, O. & Ávila Polo, R. et al.​ (2018) 
    Annals of Clinical and Translational Neurology5(10) pp. 1297​-1302​.​ DOI: https://doi.org/10.1002/acn3.632 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives​
    Kanata, E.; Thüne, K.; Xanthopoulos, K.; Ferrer, I.; Dafou, D.; Zerr, I. & Sklaviadis, T. et al.​ (2018) 
    Frontiers in Aging Neuroscience10 art. 220​.​ DOI: https://doi.org/10.3389/fnagi.2018.00220 
    Details  DOI  PMID  PMC 
  • 2018 Journal Article | 
    ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
    Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ ​Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease​
    Kanata, E.; Golanska, E.; Villar-Piqué, A.; Karsanidou, A.; Dafou, D.; Xanthopoulos, K. & Schmitz, M. et al.​ (2019) 
    Journal of Clinical Neuroscience60 pp. 124​-127​.​ DOI: https://doi.org/10.1016/j.jocn.2018.09.031 
    Details  DOI 
  • 2019 Journal Article
    ​ ​RNA editing alterations define manifestation of prion diseases​
    Kanata, E.; Llorens, F.; Dafou, D.; Dimitriadis, A.; Thüne, K.; Xanthopoulos, K. & Bekas, N. et al.​ (2019) 
    Proceedings of the National Academy of Sciences116(39) pp. 19727​-19735​.​ DOI: https://doi.org/10.1073/pnas.1803521116 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3​
    Llorens, F.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Goebel, S.; Waniek, K. & Lachmann, I. et al.​ (2019) 
    Journal of Neurology267(2) pp. 543​-550​.​ DOI: https://doi.org/10.1007/s00415-019-09610-8 
    Details  DOI 
  • 2019 Journal Article
    ​ ​CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD​
    Blennow, K.; Diaz-Lucena, D.; Zetterberg, H.; Villar-Pique, A.; Karch, A.; Vidal, E. & Hermann, P. et al.​ (2019) 
    Journal of Neurology, Neurosurgery & Psychiatry90(8) pp. 846​-853​.​ DOI: https://doi.org/10.1136/jnnp-2018-320155 
    Details  DOI 
  • 2019 Journal Article | Research Paper
    ​ ​Seeding variability of different alpha synuclein strains in synucleinopathies​
    Candelise, N.; Schmitz, M.; Llorens, F.; Villar‐Piqué, A.; Cramm, M.; Thom, T. & Silva Correia, S. M. et al.​ (2019) 
    Annals of Neurology85(5) pp. 691​-703​.​ DOI: https://doi.org/10.1002/ana.25446 
    Details  DOI  PMID  PMC 

Researcher

Sort

issue date

ASC DESC

Items per Page